1. Home
  2. FTRE vs LASR Comparison

FTRE vs LASR Comparison

Compare FTRE & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FTRE
  • LASR
  • Stock Information
  • Founded
  • FTRE 1996
  • LASR 2000
  • Country
  • FTRE United States
  • LASR United States
  • Employees
  • FTRE N/A
  • LASR N/A
  • Industry
  • FTRE Medical Specialities
  • LASR Semiconductors
  • Sector
  • FTRE Health Care
  • LASR Technology
  • Exchange
  • FTRE Nasdaq
  • LASR Nasdaq
  • Market Cap
  • FTRE 864.4M
  • LASR 903.8M
  • IPO Year
  • FTRE N/A
  • LASR 2018
  • Fundamental
  • Price
  • FTRE $9.40
  • LASR $29.73
  • Analyst Decision
  • FTRE Hold
  • LASR Strong Buy
  • Analyst Count
  • FTRE 9
  • LASR 6
  • Target Price
  • FTRE $12.06
  • LASR $27.42
  • AVG Volume (30 Days)
  • FTRE 1.5M
  • LASR 830.1K
  • Earning Date
  • FTRE 11-07-2025
  • LASR 11-06-2025
  • Dividend Yield
  • FTRE N/A
  • LASR N/A
  • EPS Growth
  • FTRE N/A
  • LASR N/A
  • EPS
  • FTRE N/A
  • LASR N/A
  • Revenue
  • FTRE $2,733,500,000.00
  • LASR $216,913,000.00
  • Revenue This Year
  • FTRE N/A
  • LASR $23.44
  • Revenue Next Year
  • FTRE N/A
  • LASR $8.73
  • P/E Ratio
  • FTRE N/A
  • LASR N/A
  • Revenue Growth
  • FTRE N/A
  • LASR 9.79
  • 52 Week Low
  • FTRE $3.97
  • LASR $6.20
  • 52 Week High
  • FTRE $25.28
  • LASR $32.27
  • Technical
  • Relative Strength Index (RSI)
  • FTRE 53.01
  • LASR 53.36
  • Support Level
  • FTRE $9.25
  • LASR $28.41
  • Resistance Level
  • FTRE $9.89
  • LASR $32.27
  • Average True Range (ATR)
  • FTRE 0.57
  • LASR 1.46
  • MACD
  • FTRE -0.12
  • LASR -0.21
  • Stochastic Oscillator
  • FTRE 45.93
  • LASR 39.82

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

Share on Social Networks: